Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04648878 · ClinicalTrials.gov registry record · NA

A Comparison of Conventional Physical Therapy, Powered Exoskeleton, and Hybrid Physical Therapy With Exoskeleton

A NA study of Stroke, sponsored by Loma Linda University.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT04648878: Completed NA study of Stroke, sponsored by Loma Linda University.

NCT04648878 is a NA study of Stroke that has completed, run by Loma Linda University. The registered enrollment target is 6 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04648878, a NA study of Stroke, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this investigator-initiated study is to establish if powered exoskeleton therapy as a part of a rehabilitation program can be used as a standard of care in stroke rehabilitation.

Primary Outcome

Subject sits in a standard armchair and stands, and at a self-selected walking speed, walks 3 meters, turns, and walks back to the chair, and sits down. They will be timed. Takes three minutes to administer.

Conditions Studied

Interventions

  • OTHER Hybrid combination of physical therapy and powered exoskeleton
  • OTHER Powered Exoskeleton Only
  • OTHER Physical Therapy only

Study Locations (1)

California

  • Loma Linda University - Loma Linda

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2021-02-14
Est. Completion 2024-12-18
Phase NA
Loma Linda University

237 total trials

What the finished NCT04648878 record still lists

NCT04648878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Hybrid combination of physical therapy and powered exoskeleton is the first listed.

NCT04648878 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04648878 about?

NCT04648878 is a clinical study titled "A Comparison of Conventional Physical Therapy, Powered Exoskeleton, and Hybrid Physical Therapy With Exoskeleton". The purpose of this investigator-initiated study is to establish if powered exoskeleton therapy as a part of a rehabilitation program can be used as a standard of care in stroke rehabilitation.

What is the current status of trial NCT04648878?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-02-14. Estimated completion is 2024-12-18.

What conditions does trial NCT04648878 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT04648878?

The interventions under investigation include: Hybrid combination of physical therapy and powered exoskeleton (OTHER), Powered Exoskeleton Only (OTHER), Physical Therapy only (OTHER).

Who is sponsoring clinical trial NCT04648878?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04648878 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04648878's enrollment target sits among peer trials

6 433rd of 454 higher than 17 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04648878, the US trial registry maintained by the National Library of Medicine. NCT04648878 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.